Zydus Lifesciences submits press release

28 Feb 2026 Evaluate

Zydus Lifesciences has submitted a press release stating that Zydus receives final approvals from USFDA for Ivermectin Tablets USP, 3 mg and Dapsone Tablets USP, 25 mg and 100 mg.

The above information is a part of company’s filings submitted to BSE.


Zydus Lifesciences Share Price

868.85 2.50 (0.29%)
07-Apr-2026 10:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1712.50
Dr. Reddys Lab 1206.20
Cipla 1205.25
Zydus Lifesciences 868.85
Lupin 2294.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×